Mauna Kea Technologies SA (EPA:ALMKT)
France · Delayed Price · Currency is EUR 0.1420
-0.0166 (-10.47%)
Jan 28, 2026, 5:35 PM CET
Mauna Kea Technologies Company Description
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally.
It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients.
The company was incorporated in 2000 and is headquartered in Paris, France.
Mauna Kea Technologies SA
| Country | France |
| Founded | 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 61 |
| CEO | Alexandre Loiseau |
Contact Details
Address: 9, rue d'Enghien Paris, 75010 France | |
| Phone | 33 1 48 24 03 45 |
| Website | maunakeatech.com |
Stock Details
| Ticker Symbol | ALMKT |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0010609263 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Alexandre Loiseau Ph.D. | Co-Founder, Chief Executive Officer and Chairman |
| Come de La Tour du Pin | Chief Financial Officer |
| Nathalie Lecoq | Chief Operating Officer |
| Frederic Banegas Ph.D. | Chief Technology Officer |
| François Lacombe Ph.D. | Chief Scientific Officer |
| Daryl Donatelli | President of U.S. and Head of Global Marketing |